Results 81 to 90 of about 57,097 (242)
Hemodynamic support in cardiogenic shock [PDF]
, 2021 Cardiogenic shock has a poor survival rate that has not significantly improved over the past decades. The aims of this thesis were to evaluate current and new therapies and to determine factors that are associated with mortality in cardiogenic shock.
Karami, M.
core +1 more source
BMC Cardiovascular DisordersBackground Acute lung injury and acute respiratory failure are frequent complications of cardiogenic shock and are associated with increased morbidity and mortality.
Akram M. Zaaqoq +4 more
doaj +1 more source
Journal of Cardiovascular Electrophysiology, EarlyView.Displays bar graphs showing outcome rates stratified by clinical and hemodynamic variables. Asterisks (*) denote statistically significant differences (p ≤ 0.05). “NS” indicates non‐significant comparisons. Percentages are shown above each bar. The top panel corresponds to acute kidney injury (blue bars), and the bottom panel corresponds to acute ...
Tess Calcagno +23 more
wiley +1 more source
Cardiogenic shock following blunt chest trauma
, 2010 Cardiac contusion, usually caused by blunt chest trauma, has been recognized with increased frequency over the past decades. Traffic accidents are the most frequent cause of cardiac contusions resulting from a direct blow to the chest.
Martínez-Quintana Efrén +5 more
core +1 more source
Impacts of Hemodynamic Support on Ventricular Arrhythmia Ablation
Journal of Cardiovascular Electrophysiology, EarlyView.ABSTRACT Background Data on the efficacy of hemodynamic support (HS) for protecting ventricular arrhythmia (VA) ablation in high‐risk heart failure (HF) patients with an impaired left ventricular function and its impact on mortality is limited. Objectives This study aimed to assess procedural efficacy, related complications, VA‐free survival, and ...
Denise Guckel +12 more
wiley +1 more source
, 1999 This retrospective study evaluates the influence of an invasive strategy of urgent coronary revascularization on the in-hospital mortality of patients with acute myocardial infarction (AMI) complicated early by cardiogenic shock.
Juan L Delcán +21 more
core +1 more source
Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock [PDF]
, 2012 The IABP-SHOCK-trial was a morbidity-based randomized controlled trial in patients with infarction-related cardiogenic shock (CS), which used the change of the quantified degree of multiorgan failure as determined by APACHE II score over a 4-day period ...
Heinroth, Konstantin M +13 more
core +1 more source
Pacing and Clinical Electrophysiology, EarlyView.Abstract Background Implantable cardioverter‐defibrillator (ICD) therapy relies on reliable right ventricular leads for pacing, sensing, and defibrillation. The INVICTA DF4 lead is an active‐fixation, quadripolar design intended to optimize implant workflow and long‐term safety and performance. Methods APOLLO was a prospective, multicenter, single‐arm,
Klaus K. Witte +13 more
wiley +1 more source
BMC Emergency Medicine, 2018 Background Extracorporeal membrane oxygenation (ECMO) is increasingly used in resuscitation of critically ill patients with documented improved survival. Few studies describe ECMO use in cardiogenic shock.
Rayan El Sibai +2 more
doaj +1 more source
Inotropic agents in cardiogenic shock
, 2020 PURPOSE OF REVIEW: Cardiogenic shock is a multifactorial and diverse entity in which inotropes are the cornerstone therapy. Although published clinical trials have focused on pharmacologic treatment of cardiogenic shock, there is lack of an established ...
Parissis, J. +3 more
core